{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:53:41Z","timestamp":1759229621546},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1002\/jps.23801","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T23:08:30Z","timestamp":1385507310000},"page":"140-151","source":"Crossref","is-referenced-by-count":18,"title":["Preformulation Study of Highly Purified Inactivated Polio Vaccine, Serotype 3"],"prefix":"10.1016","volume":"103","author":[{"given":"Wei","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Orgel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Francon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore W.","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Russell Middaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.23801_bb0010","article-title":"WHO Global Polio eradication initiative strategic plan 2004\u20132008. 1\u201340 http: www.polioeradication.org\/content\/publications\/2004stratplan.","year":"2003","journal-title":"pdf http:\/\/www.polioeradication.org\/content\/publications\/2004stratplan"},{"key":"10.1002\/jps.23801_bb0015","article-title":"WHO Pliomyelities fact sheet http:\/\/www.poliofree.org\/polio-fact-sheet.htm","year":"2011","journal-title":"http:\/\/www.poliofree.org\/polio-fact-sheet.htm"},{"issue":"5","key":"10.1002\/jps.23801_bb0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/rmv.401","article-title":"Polio eradication: The OPV paradox","volume":"13","author":"Dowdle","year":"2003","journal-title":"Rev Med Virol"},{"issue":"6","key":"10.1002\/jps.23801_bb0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1590\/S0100-879X1997000600001","article-title":"Rare adverse events associated with oral poliovirus vaccine in Brazil","volume":"30","author":"Friedrich","year":"1997","journal-title":"Braz J Med Biol Res"},{"key":"10.1002\/jps.23801_bb0030","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"issue":"20","key":"10.1002\/jps.23801_bb0035","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/jps.23801_bb0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1586\/erv.10.39","article-title":"Switching from OPV to IPV: Are we behind the schedule in Latin America?","volume":"9","author":"D","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"17","key":"10.1002\/jps.23801_bb0045","first-page":"5","article-title":"Outbreak of poliomyelitis in Tajikistan in 2010: Risk for importation and impact on polio surveillance in Europe?","volume":"15","author":"Tajikis","year":"2010","journal-title":"Eurosurveillance"},{"key":"10.1002\/jps.23801_bb0050","article-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Atkinson","year":"2008"},{"issue":"5","key":"10.1002\/jps.23801_bb0055","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"Chen","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1002\/jps.23801_bb0060","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.2994218","article-title":"Three-dimensional structure of poliovirus at 2.9A resolution","volume":"229","author":"Hogle","year":"1985","journal-title":"Science"},{"issue":"12","key":"10.1002\/jps.23801_bb0065","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1128\/JVI.79.12.7745-7755.2005","article-title":"The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes","volume":"79","author":"Bubeck","year":"2005","journal-title":"J Virol"},{"issue":"7","key":"10.1002\/jps.23801_bb0070","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pbio.0050183","article-title":"Imaging poliovirus entry in live cells","volume":"5","author":"Brandenburg","year":"2007","journal-title":"PLoS Biol"},{"issue":"1","key":"10.1002\/jps.23801_bb0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/abbi.1997.0111","article-title":"Elucidating mechanisms of thermostabilization of poliovirus by D2O and MgCl2","volume":"342","author":"Chen","year":"1997","journal-title":"Arch Biochem Biophys"},{"issue":"3,4","key":"10.1002\/jps.23801_bb0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF01311314","article-title":"Fluorescence spectrophotometric study of structural alterations in the capsid of poliovirus","volume":"78","author":"Grimmel","year":"1983","journal-title":"Arch Virol"},{"issue":"18","key":"10.1002\/jps.23801_bb0085","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/j.vaccine.2011.02.085","article-title":"Characterization and standardization of Sabin based inactivated polio vaccine: Proposal for a new antigen unit for inactivated polio vaccines","volume":"29","author":"Westdijk","year":"2011","journal-title":"Vaccine"},{"key":"10.1002\/jps.23801_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/infdis\/175.Supplement_1.S247","article-title":"Development of a more thermostable poliovirus vaccine","volume":"175","author":"Milstien","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1002\/jps.23801_bb0095","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0264-410X(00)00442-4","article-title":"Capsid and RNA stabilisation of the oral polio vaccine","volume":"19","author":"Verheyden","year":"2001","journal-title":"Vaccine"},{"issue":"10","key":"10.1002\/jps.23801_bb0100","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/pro.2144","article-title":"Improved data visualization techniques for analyzing macromolecule structural changes","volume":"21","author":"Kim","year":"2012","journal-title":"Protein Sci"},{"issue":"9","key":"10.1002\/jps.23801_bb0105","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/jps.10439","article-title":"Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: A bGCSF case study","volume":"92","author":"Kueltzo","year":"2003","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1002\/jps.23801_bb0110","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1002\/jps.22618","article-title":"Multidimensional methods for the formulation of biopharmaceuticals and vaccines","volume":"100","author":"Maddux","year":"2011","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1002\/jps.23801_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biologicals.2004.11.001","article-title":"Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method","volume":"33","author":"Rezapkin","year":"2005","journal-title":"Biologicals"},{"issue":"4","key":"10.1002\/jps.23801_bb0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1099\/0022-1317-74-4-685","article-title":"Antigenic structure of poliovirus in inactivated vaccines","volume":"74","author":"Ferguson","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1002\/jps.23801_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1099\/0022-1317-37-1-127","article-title":"Structural subunits of poliovirus particles by electron microscopy","volume":"37","author":"Boublik","year":"1977","journal-title":"J Gen Virol"},{"key":"10.1002\/jps.23801_bb0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/9780470110560.ch3","article-title":"Fluorescence techniques for studying protein structure","volume":"35","author":"Eftink","year":"1991","journal-title":"Methods Biochem Anal"},{"issue":"6","key":"10.1002\/jps.23801_bb0135","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/js960475h","article-title":"Size and conformational stability of the hepatitis A virus used to prepare VAQTA, a highly purified inactivated vaccine","volume":"86","author":"Volkin","year":"1989","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1002\/jps.23801_bb0140","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/j.1460-2075.1989.tb03541.x","article-title":"Structural factors that control conformational transitions and serotype specificity in type-3 poliovirus","volume":"8","author":"Filman","year":"1989","journal-title":"Embo J"},{"issue":"4","key":"10.1002\/jps.23801_bb0145","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/jps.22371","article-title":"Formulation development of therapeutic monoclonal antibodies using high-throughput fluorescence and static light scattering techniques: Role of conformational and colloidal stability","volume":"100","author":"Goldberg","year":"2011","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1002\/jps.23801_bb0150","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jps.22282","article-title":"Application of extrinsic fluorescence spectroscopy for the high throughput formulation screening of aluminum-adjuvanted vaccines","volume":"100","author":"Ausar","year":"2011","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1002\/jps.23801_bb0155","article-title":"Mechanism of stabilization of proteins by glycerol and sucrose","volume":"54","author":"Arakawa","year":"1982","journal-title":"Seikagaku"},{"issue":"14","key":"10.1002\/jps.23801_bb0160","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1016\/S0021-9258(19)68947-7","article-title":"The stabilization of proteins by sucrose","volume":"256","author":"Lee","year":"1981","journal-title":"J Biol Chem"},{"issue":"1,2","key":"10.1002\/jps.23801_bb0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-5173(95)04442-6","article-title":"Thermal stability of low molecular weight urokinase during heat treatment. 3. Effect of salts, sugars and Tween 80","volume":"134","author":"Foster","year":"1996","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1002\/jps.23801_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpc.2005.04.004","article-title":"Effect of polyol osmolytes on DeltaG(D), the Gibbs energy of stabilisation of proteins at different pH values","volume":"117","author":"Haque","year":"2005","journal-title":"Biophys Chem"},{"issue":"23","key":"10.1002\/jps.23801_bb0175","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1021\/bi00138a006","article-title":"Increased thermal-stability of proteins in the presence of naturally-occurring osmolytes","volume":"31","author":"Santoro","year":"1992","journal-title":"Biochemistry"},{"issue":"15","key":"10.1002\/jps.23801_bb0180","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.1073\/pnas.122225399","article-title":"Protein-solvent preferential interactions, protein hydration, and the modulation of biochemical reactions by solvent components","volume":"99","author":"Timasheff","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1002\/jps.23801_bb0185","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1073\/pnas.0930122100","article-title":"The molecular basis for the chemical denaturation of proteins by urea","volume":"100","author":"Bennion","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1002\/jps.23801_bb0190","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pep.2009.02.004","article-title":"Cooperative effects of urea and L-arginine on protein refolding","volume":"66","author":"Chen","year":"2009","journal-title":"Protein Expr Purif"},{"issue":"11","key":"10.1002\/jps.23801_bb0195","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1586\/erv.09.105","article-title":"Role of heavy water in biological sciences with an emphasis on thermostabilization of vaccines","volume":"8","author":"Sen","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1002\/jps.23801_bb0200","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1016\/S0006-3495(02)75666-X","article-title":"Effect of heavy water on protein flexibility","volume":"82","author":"Cioni","year":"2002","journal-title":"Biophys J"},{"issue":"3","key":"10.1002\/jps.23801_bb0205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/bip.20645","article-title":"Stability of globular proteins in H2O and D2O","volume":"85","author":"Efimova","year":"2007","journal-title":"Biopolymers"},{"issue":"3","key":"10.1002\/jps.23801_bb0210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0014-5793(97)01581-0","article-title":"Aggregation of beta-lactoglobulin and influence of D2O","volume":"421","author":"Verheul","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1002\/jps.23801_bb0215","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/infdis\/175.Supplement_1.S247","article-title":"Development of a more thermostable poliovirus vaccine","volume":"175","author":"Milstien","year":"1997","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1002\/jps.23801_bb0220","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/0264-410X(95)00068-C","article-title":"Thermostabilization of live virus vaccines by heavy water (D2O)","volume":"13","author":"Wu","year":"1995","journal-title":"Vaccine"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915307772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915307772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T18:22:27Z","timestamp":1647541347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915307772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0022354915307772"],"URL":"https:\/\/doi.org\/10.1002\/jps.23801","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}